Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 10 | 2010 | 591 | 0.770 |
Why?
|
| Long-Term Potentiation | 5 | 2010 | 109 | 0.750 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 2 | 2014 | 10 | 0.680 |
Why?
|
| Receptors, Dopamine D1 | 2 | 2015 | 45 | 0.680 |
Why?
|
| Benzazepines | 5 | 2015 | 33 | 0.670 |
Why?
|
| Glucose Intolerance | 1 | 2018 | 41 | 0.580 |
Why?
|
| Sleep Deprivation | 1 | 2018 | 29 | 0.580 |
Why?
|
| GAP-43 Protein | 2 | 2006 | 9 | 0.480 |
Why?
|
| Catha | 1 | 2015 | 1 | 0.480 |
Why?
|
| Methamphetamine | 3 | 2014 | 167 | 0.480 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2015 | 12 | 0.480 |
Why?
|
| Alkaloids | 1 | 2015 | 46 | 0.460 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 83 | 0.450 |
Why?
|
| Dopamine Agents | 1 | 2014 | 28 | 0.420 |
Why?
|
| Guinea Pigs | 8 | 2015 | 144 | 0.410 |
Why?
|
| Locomotion | 1 | 2014 | 104 | 0.400 |
Why?
|
| Plant Extracts | 1 | 2015 | 303 | 0.370 |
Why?
|
| Synaptic Transmission | 3 | 2010 | 156 | 0.310 |
Why?
|
| Benzoxazines | 2 | 2019 | 46 | 0.280 |
Why?
|
| Dopamine Agonists | 1 | 2006 | 34 | 0.250 |
Why?
|
| Animals | 19 | 2025 | 16695 | 0.240 |
Why?
|
| alpha-Defensins | 1 | 2025 | 22 | 0.230 |
Why?
|
| Colitis | 1 | 2025 | 69 | 0.210 |
Why?
|
| Particulate Matter | 1 | 2025 | 80 | 0.210 |
Why?
|
| Synapses | 4 | 1992 | 184 | 0.200 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2025 | 101 | 0.200 |
Why?
|
| Air Pollutants | 1 | 2025 | 127 | 0.200 |
Why?
|
| Electric Stimulation | 7 | 2006 | 198 | 0.200 |
Why?
|
| Electrophysiology | 3 | 2001 | 138 | 0.200 |
Why?
|
| Antibodies, Monoclonal | 1 | 2025 | 301 | 0.200 |
Why?
|
| Gene Expression | 1 | 2006 | 692 | 0.200 |
Why?
|
| Environmental Exposure | 1 | 2025 | 247 | 0.190 |
Why?
|
| Neurophysiology | 1 | 2001 | 10 | 0.180 |
Why?
|
| Functional Laterality | 1 | 2001 | 89 | 0.180 |
Why?
|
| Presynaptic Terminals | 1 | 2001 | 54 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 1112 | 0.160 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2022 | 222 | 0.160 |
Why?
|
| Neurons | 5 | 2011 | 1246 | 0.160 |
Why?
|
| HIV Infections | 3 | 2019 | 2535 | 0.150 |
Why?
|
| Jaundice | 1 | 2018 | 7 | 0.140 |
Why?
|
| Models, Biological | 1 | 2001 | 711 | 0.140 |
Why?
|
| HIV Protease Inhibitors | 1 | 2018 | 24 | 0.140 |
Why?
|
| Glucuronosyltransferase | 1 | 2018 | 29 | 0.140 |
Why?
|
| Male | 12 | 2018 | 22779 | 0.140 |
Why?
|
| Steroid Hydroxylases | 1 | 2016 | 3 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 479 | 0.130 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2016 | 56 | 0.130 |
Why?
|
| Central Nervous System Diseases | 1 | 2016 | 32 | 0.130 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2016 | 51 | 0.120 |
Why?
|
| Electrolytes | 1 | 2016 | 30 | 0.120 |
Why?
|
| Minerals | 1 | 2016 | 52 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2018 | 733 | 0.120 |
Why?
|
| Sulpiride | 1 | 2015 | 6 | 0.120 |
Why?
|
| Masseter Muscle | 2 | 1992 | 4 | 0.120 |
Why?
|
| Malnutrition | 1 | 2016 | 44 | 0.120 |
Why?
|
| Vitamins | 1 | 2016 | 81 | 0.120 |
Why?
|
| Incidence | 1 | 2018 | 1054 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 860 | 0.120 |
Why?
|
| Motor Activity | 2 | 2015 | 438 | 0.110 |
Why?
|
| Dietary Supplements | 1 | 2016 | 208 | 0.110 |
Why?
|
| Lipids | 1 | 2016 | 256 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2006 | 574 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 1 | 2015 | 181 | 0.100 |
Why?
|
| HIV-1 | 1 | 2019 | 747 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2006 | 884 | 0.100 |
Why?
|
| Pregnancy | 1 | 2018 | 1737 | 0.100 |
Why?
|
| Mandibular Nerve | 1 | 1992 | 2 | 0.100 |
Why?
|
| Neural Conduction | 1 | 1992 | 17 | 0.100 |
Why?
|
| Aging | 2 | 2022 | 764 | 0.100 |
Why?
|
| Action Potentials | 6 | 2001 | 246 | 0.090 |
Why?
|
| Humans | 12 | 2025 | 42163 | 0.090 |
Why?
|
| Female | 6 | 2018 | 24018 | 0.090 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2011 | 59 | 0.090 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 234 | 0.090 |
Why?
|
| Strychnine | 1 | 1991 | 2 | 0.090 |
Why?
|
| Reticular Formation | 1 | 1991 | 4 | 0.090 |
Why?
|
| Chlorides | 1 | 2011 | 59 | 0.090 |
Why?
|
| Bicuculline | 1 | 1991 | 18 | 0.090 |
Why?
|
| alpha-Synuclein | 1 | 2011 | 59 | 0.090 |
Why?
|
| Motor Neurons | 1 | 1991 | 88 | 0.080 |
Why?
|
| Young Adult | 2 | 2018 | 4936 | 0.080 |
Why?
|
| Dopamine Antagonists | 2 | 2010 | 48 | 0.080 |
Why?
|
| Risk Factors | 1 | 2018 | 3942 | 0.080 |
Why?
|
| Adult | 4 | 2018 | 13458 | 0.080 |
Why?
|
| Sleep | 1 | 1991 | 179 | 0.080 |
Why?
|
| Bupivacaine | 1 | 1989 | 1 | 0.080 |
Why?
|
| Menisci, Tibial | 1 | 1989 | 3 | 0.080 |
Why?
|
| Pain, Postoperative | 1 | 1989 | 28 | 0.070 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2008 | 34 | 0.070 |
Why?
|
| Cyclopropanes | 2 | 2019 | 42 | 0.070 |
Why?
|
| Alkynes | 2 | 2019 | 50 | 0.070 |
Why?
|
| Substance-Related Disorders | 2 | 2008 | 825 | 0.070 |
Why?
|
| Enflurane | 1 | 1986 | 1 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2015 | 2111 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2006 | 151 | 0.060 |
Why?
|
| Rats | 5 | 2008 | 3701 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2005 | 15 | 0.060 |
Why?
|
| Autoradiography | 1 | 2005 | 35 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 134 | 0.060 |
Why?
|
| Genotype | 2 | 2018 | 796 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2025 | 68 | 0.050 |
Why?
|
| Time Factors | 2 | 2005 | 1848 | 0.050 |
Why?
|
| Mice | 4 | 2025 | 6490 | 0.050 |
Why?
|
| Colon | 1 | 2025 | 118 | 0.050 |
Why?
|
| Ibogaine | 1 | 2002 | 2 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 928 | 0.050 |
Why?
|
| Cats | 2 | 1992 | 80 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2022 | 61 | 0.050 |
Why?
|
| Depression | 1 | 2008 | 837 | 0.040 |
Why?
|
| Homeostasis | 1 | 2022 | 193 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 184 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 1554 | 0.040 |
Why?
|
| Pharmacogenetics | 1 | 2019 | 63 | 0.040 |
Why?
|
| Picrotoxin | 2 | 1988 | 14 | 0.040 |
Why?
|
| Bilirubin | 1 | 2018 | 19 | 0.030 |
Why?
|
| Middle Aged | 3 | 2018 | 11819 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 118 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2002 | 1066 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 2016 | 31 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 1 | 2016 | 17 | 0.030 |
Why?
|
| Zambia | 1 | 2016 | 47 | 0.030 |
Why?
|
| Phosphates | 1 | 2016 | 54 | 0.030 |
Why?
|
| Magnesium | 1 | 2016 | 93 | 0.030 |
Why?
|
| Dietary Fats | 1 | 2016 | 117 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 438 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2016 | 115 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2016 | 158 | 0.030 |
Why?
|
| Anti-HIV Agents | 1 | 2019 | 475 | 0.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2016 | 225 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 727 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 1992 | 46 | 0.020 |
Why?
|
| Muscle Development | 1 | 1992 | 51 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1992 | 209 | 0.020 |
Why?
|
| Saccharin | 1 | 1992 | 9 | 0.020 |
Why?
|
| Brain | 2 | 2011 | 1452 | 0.020 |
Why?
|
| Axons | 1 | 1992 | 116 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 82 | 0.020 |
Why?
|
| CHO Cells | 1 | 2011 | 123 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 241 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 228 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 1991 | 48 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 182 | 0.020 |
Why?
|
| Cerebral Cortex | 2 | 1992 | 303 | 0.020 |
Why?
|
| Serotonin Antagonists | 1 | 2010 | 24 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2011 | 138 | 0.020 |
Why?
|
| Dopamine | 1 | 2011 | 272 | 0.020 |
Why?
|
| Piperazines | 1 | 2010 | 117 | 0.020 |
Why?
|
| Aged | 1 | 2022 | 7982 | 0.020 |
Why?
|
| Injections, Intra-Articular | 1 | 1989 | 2 | 0.020 |
Why?
|
| Arthroscopy | 1 | 1989 | 3 | 0.020 |
Why?
|
| Analgesia | 1 | 1989 | 11 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1986 | 132 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2008 | 40 | 0.020 |
Why?
|
| Motor Endplate | 1 | 1988 | 3 | 0.020 |
Why?
|
| Barium | 1 | 1988 | 16 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 116 | 0.020 |
Why?
|
| Tetany | 1 | 1988 | 2 | 0.020 |
Why?
|
| Random Allocation | 1 | 1989 | 145 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 1988 | 34 | 0.020 |
Why?
|
| Neuromuscular Junction | 1 | 1988 | 34 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 1989 | 305 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 200 | 0.020 |
Why?
|
| Neuroglia | 1 | 1988 | 131 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1988 | 506 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1989 | 249 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2008 | 369 | 0.020 |
Why?
|
| Peptides | 1 | 1988 | 357 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2008 | 1010 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 1804 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 5950 | 0.010 |
Why?
|
| Verapamil | 1 | 1984 | 7 | 0.010 |
Why?
|
| Kinetics | 1 | 1986 | 698 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 1737 | 0.010 |
Why?
|
| Tabernaemontana | 1 | 2002 | 2 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2008 | 641 | 0.010 |
Why?
|
| Hallucinogens | 1 | 2002 | 29 | 0.010 |
Why?
|
| Evoked Potentials | 2 | 1992 | 90 | 0.010 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1992 | 6 | 0.010 |
Why?
|
| Quinoxalines | 1 | 1992 | 17 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 1992 | 44 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1992 | 93 | 0.010 |
Why?
|
| Neurites | 1 | 1992 | 40 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1992 | 221 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1992 | 133 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1988 | 12 | 0.000 |
Why?
|
| Rabbits | 1 | 1988 | 292 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1988 | 1617 | 0.000 |
Why?
|
| Dendrites | 1 | 1984 | 57 | 0.000 |
Why?
|
| Calcium | 1 | 1984 | 487 | 0.000 |
Why?
|